Download Citation
Article Source:
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
Moots RJ,
Xavier RM,
Mok CC,
Rahman MU,
Tsai WC,
et al.
(2017)
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
PLOS ONE 12(4): e0175207.
https://doi.org/10.1371/journal.pone.0175207